Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$21,695,387
-$885,246 QoQ
Shares Held
85,425
-7.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
5.84%
of 13F equity value
Holder Rank
#710
of 4,676 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atle Fund Management AB holds $117,376,751 across 6 Drug Manufacturers - General names. JNJ ranks #3 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,821 | $35,768,205 | |
| 2 | MRK |
Merck & Co., Inc.
|
189,357 | $24,332,374 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
85,425 | $21,695,387 | |
| 4 | ABBV |
AbbVie Inc.
|
64,325 | $16,186,743 | |
| 5 | BIIB |
Biogen Inc.
|
62,781 | $13,564,462 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
46,142 | $5,829,580 |
All Filings in JNJ
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,695,387 | 85,425 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $22,580,633 | 92,377 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||